Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.56 |
| ▸ | CA1 | P00915 | 5/20 | 0.56 |
| ▸ | CTSK | P43235 | 8/20 | 0.50 |
| ▸ | CTSS | P25774 | 8/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.44 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17133668 | 0.90 | CA2 (0.54) | CA2CA1CTSKCTSSCTSL | |
| SCHEMBL17537317 | 0.90 | CA2 (0.56) | CA2CA1CTSKCTSSCPB2 | |
| SCHEMBL17133689 | 0.90 | CA2 (0.56) | CA2CA1CTSKCTSSCPB2 | |
| SCHEMBL17537318 | 0.89 | CTSK (0.56) | CA2CA1CTSKCTSSCPB2 | |
| SCHEMBL17133652 | 0.89 | CTSK (0.56) | CA2CA1CTSKCTSSCPB2 | |
| SCHEMBL15083612 | 0.89 | CTSK (0.63) | CA2CA1CTSKCTSSTLR2 | |
| SCHEMBL17133720 | 0.89 | CTSK (0.63) | CA2CA1CTSKCTSSTLR2 | |
| SCHEMBL17133688 | 0.88 | CTSK (0.58) | CA2CA1CTSKCTSSTLR2 | |
| SCHEMBL29301814 | 0.87 | CA2 (0.56) | CA2CA1CTSKCTSSCPB2 | |
| SCHEMBL17133699 | 0.82 | CTSK (0.50) | CA2CA1CTSKCTSSCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9388123-B2 | LSD1-selective inhibitor having lysine structure | KYOTO UNIVERSITY (JP) | 2016-07-12 | — | — | US | disclosed |
| US-20160039748-A1 | LSD1-SELECTIVE INHIBITOR HAVING LYSINE STRUCTURE | KYOTO UNIVERSITY (JP) | 2016-02-11 | — | — | US | disclosed |
| EP-2927212-A1 | LSD1-SELECTIVE INHIBITOR HAVING LYSINE STRUCTURE | Kyoto University (JP) | 2015-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039748-A1 | LSD1-SELECTIVE INHIBITOR HAVING LYSINE STRUCTURE | KDM1A, DOT1L, KDM1B | CA2 2062/4885CA1 3293/4885CTSK 2479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.